Article summary
This secondary analysis of two Phase II randomised trials (n=53) examined mystical-type experiences during MDMA-assisted therapy for chronic PTSD. MDMA sessions produced higher scores than active placebo, and positive mood experiences were associated with greater reductions in PTSD symptoms, while overall mystical experiences and other aspects showed weaker, non-significant links.
Continue to the original publication for the complete article.